Canadian Solar Inc.


CSIQ

reported fourth-quarter 2021 adjusted earnings of 17 cents per share, which missed the Zacks Consensus Estimate of 38 cents by 55.3%. However, the bottom line improved 21.4% from the fourth-quarter 2020 reported figure.

Barring one-time items, Canadian Solar posted GAAP earnings of 39 cents compared with 11 cents in the prior-year quarter.

For 2021, the company reported adjusted earnings of $1.13 per share, down from $2.16 generated in 2020.

Total Revenues

This solar cell manufacturer’s total revenues of $1,528.7 million missed the Zacks Consensus Estimate of $1,545 million by 1.1%. The top line however improved a solid 46.9% from $1,040.7 million reported in fourth-quarter 2020.

For 2021, the company generated revenues worth $5.28 billion, up from $3.48 billion reported in 2020.

Operational Update

Solar module shipments in the quarter totaled 3.83 gigawatts (GW), which came in a bit above the mid-point of the guided range of 3.7-3.9 GW. This includes 263 megawatts (MWs) for the company’s utility-scale solar power projects. Total module shipments increased 28% on a year-over-year basis.

Canadian Solar’s gross margin was 19.7% in the quarter, above the guided range of 14-16%.

Total operating expenses were $234 million, up 68.3% year over year. The increase was due to higher shipping and handling expenses as well as research and development expenses.

Interest expenses were $15.5 million, down from $18 million recorded in the year-ago period.

Financial Update

As of Dec 31, 2021, Canadian Solar’s cash and cash equivalents totaled $869.8 million, down from $1,178.8 million on Dec 31, 2020.

Long-term borrowings as of Dec 31, 2021 were $523.6 million, up from $446.1 million on Dec 31, 2020.

Guidance

For the first quarter of 2022, Canadian Solar expects total module shipments of 3.6-3.8 GW including approximately 210 MW of module shipments to its projects. Total revenues are expected in the range of $1.25-$1.35 billion. The gross margin is expected between 14.5% and 15.5%.

For 2022, the company has hiked its expectations for total revenues to the range of $7.0-$7.5 billion from $6.5-$7.0 billion guided previously.

Zacks Rank

Canadian Solar currently carries a Zacks Rank #4 (Sell).

You can see


the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here


.

Recent Solar Releases

Enphase Energy


ENPH

reported fourth-quarter 2021 adjusted earnings of 73 cents per share, which surpassed the Zacks Consensus Estimate of 57 cents by 28.1%. The bottom line increased 43.1% from 51 cents per share reported in the prior-year quarter.

Enphase Energy’s fourth-quarter revenues of $412.7 million beat the Zacks Consensus Estimate of $403 million by 2.4%. ENPH’s top line soared 55.8% from the year-ago quarter’s $264.8 million, driven by strong demand for its microinverter systems.

SunPower


SPWR

reported fourth-quarter 2021 loss of 7 cents per share, in contrast to the Zacks Consensus Estimate of earnings of 4 cents. The bottom line significantly declined from earnings of 14 cents per share reported in the prior-year quarter.

SunPower’s total revenues came in at $384.2 million, which declined 13.8% from the prior-year quarter. SPWR’s top line also beat the Zacks Consensus Estimate of $379.1 million by 1.3%.

Sunrun


RUN

reported fourth-quarter 2021 earnings of 10 cents per share, in line with the Zacks Consensus Estimate. The bottom line significantly improved from a loss of 6 cents per share reported in the prior-year quarter.

Sunrun’s total revenues for the quarter came in at $435.2 million, which increased 35.8% from the prior-year quarter. RUN’s top line also surpassed the Zacks Consensus Estimate by 11%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research